182 results on '"Gackowski, Daniel"'
Search Results
2. The level of active DNA demethylation compounds in leukocytes and urine samples as potential epigenetic biomarkers in breast cancer patients
3. Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications
4. Dynamic changes in genomic 5-hydroxymethyluracil and N6-methyladenine levels in the Drosophila melanogaster life cycle and in response to different temperature conditions
5. Selective Estrogen Receptor Modulators' (SERMs) Influence on TET3 Expression in Breast Cancer Cell Lines with Distinct Biological Subtypes.
6. Exploring the crop epigenome: a comparison of DNA methylation profiling techniques
7. The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy response
8. LINE-1 transcription in round spermatids is associated with accretion of 5-carboxylcytosine in their open reading frames
9. PB1914: UNPRECEDENTED ACCUMULATION OF 5-HYDROXYMETHYLURACIL IN CHRONIC LYMPHOCYTIC LEUKEMIA –POTENTIAL SOURCES AND CLINICAL IMPLICATIONS
10. Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia
11. Exploring the crop epigenome: a comparison of DNA methylation profiling techniques
12. Exploring the crop epigenome: a comparison of DNA methylation profiling techniques
13. Mass spectrometry reveals the presence of specific set of epigenetic DNA modifications in the Norway spruce genome
14. Global DNA 5-hydroxymethylcytosine level and its chromosomal distribution in four rye (Secale L.) species
15. Unprecedentedly High Level of Intracellular Vitamin C and DNA Epigenetic Marks in Prostate: Relevant for Male Fertility?
16. In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease
17. Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions—benign adenomas and inflammatory bowel disease
18. Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study
19. Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes
20. The Membrane Electrical Potential and Intracellular pH as Factors Influencing Intracellular Ascorbate Concentration and Their Role in Cancer Treatment
21. An IDH-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer
22. An IDH-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer.
23. Targeted DNA oxidation by LSD1–SMAD2/3 primes TGF-β1/ EMT genes for activation or repression
24. Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients
25. Mass spectrometry reveals the presence of specific set of epigenetic DNA modifications in the Norway spruce genome
26. Helicobacter pylori infection is associated with oxidatively damaged DNA in human leukocytes and decreased level of urinary 8-oxo-7,8-dihydroguanine
27. Contribution of hMTH1 to the Maintenance of 8-Oxoguanine Levels in Lung DNA of Non–Small-Cell Lung Cancer Patients
28. MOESM1 of In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease
29. Additional file 3: of Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditionsâ benign adenomas and inflammatory bowel disease
30. Additional file 2: of Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditionsâ benign adenomas and inflammatory bowel disease
31. Additional file 1: of Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditionsâ benign adenomas and inflammatory bowel disease
32. TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins
33. 5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively
34. Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation
35. Systemowa równowaga antyoksyacyjna u pacjentów bez klinicznej manifestacji miażdżycy
36. Correction: Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2′-deoxycytidine level in cultured cancerous cell lines
37. Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2′-deoxycytidine level in cultured cancerous cell lines
38. Systemic oxidoreductive balance and vascular function in individuals without clinical manifestation of atherosclerosis
39. Urinary Measurement of Epigenetic DNA Modifications: A Non-Invasive Assessment of the Whole-Body Epigenetic Status in Healthy Subjects and Colorectal Cancer Patients
40. 8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients
41. Systemic oxidoreductive balance in patients without clinical manifestation of atherosclerosis.
42. Tissue-Specific Differences in DNA Modifications (5-Hydroxymethylcytosine, 5-Formylcytosine, 5-Carboxylcytosine and 5-Hydroxymethyluracil) and Their Interrelationships
43. TET2 and MSH6: A Novel Role for MMR in the Pathogenesis of Myeloid Malignancies
44. Modulation of TET2 Activity with Ascorbic Acid in Myeloid Neoplasia: Diagnostic and Therapeutic Implications
45. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study
46. Comparison of the Absolute Level of Epigenetic Marks 5-Methylcytosine, 5-Hydroxymethylcytosine, and 5-Hydroxymethyluracil Between Human Leukocytes and Sperm1
47. Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine
48. Comparison of Oxidative Stress/DNA Damage in Semen and Blood of Fertile and Infertile Men
49. Measurement of DNA oxidation in human cells by chromatographic and enzymic methods
50. Measurement of DNA oxidation in human cells by chromatographic and enzymatic methods
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.